glp 1 3 months GLP-1 Weight Loss Results 3 Months Transformation Weight Loss

Objective To determine whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with an increased risk of suicidal ideation, self-harm, and suicide among patients with type 2 diabetes compared with the use of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 (SGLT-2) inhibitors

In addition, there is no consensus on screening or evaluating patients for thyroid cancer prior to or during treatment with GLP1 RA

But how much teeth do these claims about GLP-1 agonists have?

Apart from genetics, inflammation processes have been hypothesized to be of importance for the development of obesity and related aspects like insulin resistance